Health Insurance MarketplaceSM, 11583-11585 [2017-03598]

Download as PDF Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices asabaliauskas on DSK3SPTVN1PROD with NOTICES meetings, subsequent workgroup reconsiderations, and final decisions, we are able to consider only those comments received in writing by the close of the public meeting at which the request is discussed. IV. Security, Building, and Parking Guidelines The meetings are held within the CMS Complex which is not open to the general public. Visitors to the complex are required to show a valid Government issued photo identification at the time of entry. As of October, 10, 2015, visitors seeking access to federal agency facilities using their state-issued driver’s license or identification cards must present proper identification issued by a state that is compliant with the REAL ID Act of 2005 (Pub. L. 109– 13, 119 Statute 302, enacted on May 11, 2005) or a state that has received an extension. What constitutes proper identification and whether a driver’s license is acceptable identification for accessing a federal facility may vary, based on which state issued the driver’s license. For detailed information, please refer to the Department of Homeland Security (DHS) Web site at: http:// www.dhs.gov. When planning to visit a federal facility, visitors who have further questions about acceptable forms of identification are encouraged to contact the facility to determine acceptable identification. Visitors will also be subject to a vehicle security inspection before access to the complex is granted. Participants not in possession of a valid identification or who are in possession of prohibited items will be denied access to the complex. Prohibited items on federal property include but are not limited to, alcoholic beverages, illegal narcotics, explosives, firearms or other dangerous weapons (including pocket knives), dogs or other animals except service animals. Once cleared for entry to the complex participants will be directed to visitor parking by a security officer. To ensure expedited entry into the building it is recommended that participants have their government ID and a copy of their written meeting registration confirmation readily available and that they do not bring large/bulky items into the building. Participants are reminded that photography on the CMS complex is prohibited. We have also been declared a tobacco free campus and violators are subject to legal action. In planning arrival time, we recommend allowing additional time to clear security. Individuals who are not registered in advance will not be permitted to enter VerDate Sep<11>2014 17:20 Feb 23, 2017 Jkt 241001 the building and will be unable to attend the meeting. The invited guests may not enter the building earlier than 45 minutes before the convening of the meeting each day. Guest access to the complex is limited to the meeting area, the main entrance lobby, and the cafeteria. If a visitor is found outside of those areas without proper escort they may be escorted off of the premises. Also, be mindful that there will be an opportunity for everyone to speak and we request that everyone waits for the appropriate time to present their product and opinions. Disruptive behavior will not be tolerated and may result in removal from the meetings and escort from the complex. No visitor is allowed to attach USB cables, thumb drives or any other equipment to any CMS information technology (IT) system or hardware for any purpose at any time. Additionally, our staff is prohibited from taking such actions on behalf of a visitor or utilizing any removable media provided by a visitor. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set-up, safety, or timely arrival of any personal belongings or items used for demonstration or to support a presentation. Special arrangements and approvals are required at least 2 weeks prior to each public meeting to bring pieces of equipment or medical devices. These arrangements need to be made directly with the CMS’ Public Meeting Coordinator. It is possible that certain requests made in advance of the public meeting could be denied because of unique safety, security or handling issues related to the equipment. A minimum of 2 weeks is required for approvals and security procedures. Any request not submitted at least 2 weeks in advance of the public meeting will be denied. Foreign National Visitors are defined as Non-US Citizens, and non-lawful permanent residents, non-resident aliens or non-green-card holders. Attendees that are foreign nationals must identify themselves as such, and provide the following information for security clearance to the public meeting coordinator by the date specified in the DATES section of this notice: • Building to Visit/Destination. • Visit start date, start time, end date, end time. • Visitor full name. • Gender. • Visitor Title. • Visitor Organization/Employer. • Citizenship. • Birth Place (City, Country). • Date of Birth. PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 11583 • ID Type (Passport or State Department ID). • Passport issued by Country. • ID (passport) Number. • ID (passport) issue date. • ID (passport) expiration date. • Visa Type. • Visa Number. • Purpose of Visit. Dated: February 16, 2017. Patrick Conway, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2017–03557 Filed 2–23–17; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–7044–N] Health Insurance MarketplaceSM, Medicare, Medicaid, and Children’s Health Insurance Programs; Meeting of the Advisory Panel on Outreach and Education (APOE), March 22, 2017 Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of meeting. AGENCY: This notice announces the next meeting of the Advisory Panel on Outreach and Education (APOE) (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of consumer education strategies concerning the Health Insurance MarketplaceSM,1 Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP). This meeting is open to the public. DATES: Meeting Date: Wednesday, March 22, 2017 8:30 a.m. to 4:00 p.m. eastern daylight time (e.d.t). Deadline for Meeting Registration, Presentations, Special Accommodations and Comments: Wednesday, March 8, 2017, 5:00 p.m., (e.d.t.). ADDRESSES: Meeting Location: U.S. Department of Health & Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Room 505A, Conference Room, Washington, DC 20201. Presentations and Written Comments: Presentations and written comments SUMMARY: 1 Health Insurance MarketplaceSM and MarketplaceSM are service marks of the U.S. Department of Health & Human Services. E:\FR\FM\24FEN1.SGM 24FEN1 11584 Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices asabaliauskas on DSK3SPTVN1PROD with NOTICES should be submitted to: Thomas Dudley, Designated Federal Official (DFO), Office of Communications, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Mailstop S1–05–06, Baltimore, MD 21244–1850 or via email at Thomas.Dudley@cms.hhs.gov. Registration: The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register at the Web site https://www.regonline.com/ apoemar2017meeting or by contacting the DFO as listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should contact the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Thomas Dudley, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1–05–06, Baltimore, MD 21244– 1850, 410–786–1442, email Thomas.Dudley@cms.hhs.gov. Additional information about the APOE is available on the Internet at: http:// www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690–6145. SUPPLEMENTARY INFORMATION: I. Background The Advisory Panel for Outreach and Education (APOE) (the Panel) is governed by the provisions of Federal Advisory Committee Act (FACA) (Pub. L. 92–463), as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a) and sec. 10(a) of Public Law 92–463 (5 U.S.C. App. 2, sec. 10(a) and 41 CFR 102–3). The Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) signed the charter establishing the Citizen’s Advisory Panel on Medicare Education 2 (the predecessor to the APOE) on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make recommendations to the Secretary and the Administrator of the Centers for Medicare & Medicaid 2 We note that the Citizen’s Advisory Panel on Medicare Education is also referred to as the Advisory Panel on Medicare Education (65 FR 4617). The name was updated in the Second Amended Charter approved on July 24, 2000. VerDate Sep<11>2014 17:20 Feb 23, 2017 Jkt 241001 Services (CMS) on the effective implementation of national Medicare education programs, including with respect to the Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 (Pub. L. 105–33). The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108–173) expanded the existing health plan options and benefits available under the M+C program and renamed it the Medicare Advantage (MA) program. We have had substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options available and better tools to evaluate these options. The successful MA program implementation required CMS to consider the views and policy input from a variety of private sector constituents and to develop a broad range of public-private partnerships. In addition, Title I of the MMA authorized the Secretary and the Administrator of CMS (by delegation) to establish the Medicare prescription drug benefit. The drug benefit allows beneficiaries to obtain qualified prescription drug coverage. In order to effectively administer the MA program and the Medicare prescription drug benefit, we have substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options and benefits available, and to develop better tools to evaluate these plans and benefits. The Affordable Care Act (Patient Protection and Affordable Care Act, Pub. L. 111–148, and Health Care and Education Reconciliation Act of 2010, Pub. L. 111–152) expanded the availability of other options for health care coverage and enacted a number of changes to Medicare as well as to Medicaid and the Children’s Health Insurance Program (CHIP). Qualified individuals and qualified employers are now able to purchase private health insurance coverage through a competitive marketplace, called an Affordable Insurance Exchange (also called Health Insurance MarketplaceSM or MarketplaceSM). In order to effectively implement and administer these changes, we must provide information to consumers, providers, and other stakeholders through education and outreach programs regarding how existing programs will change and the expanded range of health coverage options available, including private health insurance coverage through the MarketplaceSM. The Panel allows us to consider a broad range of views and information from interested audiences in connection with PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 this effort and to identify opportunities to enhance the effectiveness of education strategies concerning the Affordable Care Act. The scope of this panel also includes advising on issues pertaining to the education of providers and stakeholders with respect to the Affordable Care Act and certain provisions of the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted as part of the American Recovery and Reinvestment Act of 2009 (ARRA). On January 21, 2011, the Panel’s charter was renewed and the Panel was renamed the Advisory Panel for Outreach and Education. The Panel’s charter was most recently renewed on January 21, 2017, and will terminate on January 21, 2019 unless renewed by appropriate action. Under the current charter, the APOE will advise the Secretary and the Administrator on optimal strategies for the following: • Developing and implementing education and outreach programs for individuals enrolled in, or eligible for, Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP), or coverage available through the Health Insurance MarketplaceSM. • Enhancing the federal government’s effectiveness in informing Health Insurance MarketplaceSM, Medicare, Medicaid, and CHIP consumers, issuers, providers, and stakeholders, through education and outreach programs, on issues regarding these programs, including the appropriate use of publicprivate partnerships to leverage the resources of the private sector in educating beneficiaries, providers, and stakeholders. • Expanding outreach to vulnerable and underserved communities, including racial and ethnic minorities, in the context of Health Insurance MarketplaceSM, Medicare, Medicaid, and CHIP education programs. • Assembling and sharing an information base of ‘‘best practices’’ for helping consumers evaluate health coverage options. • Building and leveraging existing community infrastructures for information, counseling, and assistance. • Drawing the program link between outreach and education, promoting consumer understanding of health care coverage choices, and facilitating consumer selection/enrollment, which in turn support the overarching goal of improved access to quality care, including prevention services, envisioned under the Affordable Care Act. E:\FR\FM\24FEN1.SGM 24FEN1 Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices The current members of the Panel are: Kellan Baker, Associate Director, Center for American Progress; Robert Blancato, President, Matz, Blancato & Associates; Dale Blasier, Professor of Orthopaedic Surgery, Department of Orthopaedics, Arkansas Children’s Hospital; Deborah Britt, Executive Director of Community & Public Relations, Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of Pediatrics & Public Health, The Ohio State University, Nationwide Children’s Hospital; Josephine DeLeon, Director, Anti-Poverty Initiatives, Catholic Charities of California; Robert Espinoza, Vice President of Policy, Paraprofessional Healthcare Institute; Louise Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Roanne Osborne-Gaskin, M.D., Senior Medical Director, MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation Support, Independent Contractor; Brendan Riley, Outreach and Enrollment Coordinator, NC Community Health Center Association; Alvia Siddiqi, Medicaid Managed Care Community Network (MCCN) Medical Director, Advocate Physician Partners, Carla Smith, Executive Vice President, Healthcare Information and Management Systems Society (HIMSS); Tobin Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors; and Paula Villescaz, Senior Consultant, Assembly Health Committee, California State Legislature. asabaliauskas on DSK3SPTVN1PROD with NOTICES II. Provisions of This Notice In accordance with section 10(a) of the FACA, this notice announces a meeting of the APOE. The agenda for the March 22, 2017 meeting will include the following: • Welcome and listening session with CMS leadership • Recap of the previous (September 21, 2016) meeting • Affordable Care Act initiatives • An opportunity for public comment • Meeting summary, review of recommendations, and next steps Individuals or organizations that wish to make a 5-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Individuals not wishing to make an oral presentation may submit written comments to the DFO at the address listed in the ADDRESSES section of this VerDate Sep<11>2014 17:20 Feb 23, 2017 Jkt 241001 notice by the date listed in the DATES section of this notice. III. Security, Building, and Parking Guidelines This meeting will be held in a federal government building; therefore, federal security measures are applicable. The Real ID Act, enacted in 2005, establishes minimum standards for the issuance of state-issued driver’s licenses and identification (ID) cards. It prohibits federal agencies from accepting an official driver’s license or ID card from a state unless the Department of Homeland Security determines that the state meets these standards. Beginning October 2015, photo IDs (such as a valid driver’s license) issued by a state or territory not in compliance with the Real ID Act will not be accepted as identification to enter federal buildings. Visitors from these states/territories will need to provide alternative proof of identification (such as a valid passport) to gain entrance into CMS buildings. The current list of states from which a federal agency may accept driver’s licenses for an official purpose is found at http://www.dhs.gov/real-idenforcement-brief. We recommend that confirmed registrants arrive reasonably early, but no earlier than 45 minutes prior to the start of the meeting, to allow additional time to clear security. Security measures include the following: • Presentation of government issued photographic identification to the Federal Protective Service or Guard Service personnel. • Inspection of vehicle’s interior and exterior (this includes engine and trunk inspection) at the entrance to the grounds. Parking permits and instructions will be issued after the vehicle inspection. • Inspection, via metal detector or other applicable means, of all persons entering the building. We note that all items brought into CMS, whether personal or for the purpose of presentation or to support a presentation, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set up, safety, or timely arrival of any personal belongings or items used for presentation or to support a presentation. Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 45 minutes prior to the convening of the meeting. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 11585 All visitors must be escorted in areas other than the lower and first floor levels in the Central Building. Authority: Sec. 1114(f) of the Social Security Act (42 U.S.C. 1314(f)), sec. 222 of the Public Health Service Act (42 U.S.C. 217a), and sec. 10(a) of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a) and 41 CFR 102–3). Dated: February 16, 2017. Patrick Conway, Acting Administrator Centers for Medicare & Medicaid Services. [FR Doc. 2017–03598 Filed 2–23–17; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: HHS gives notice concerning the final effect of the HHS decision to designate a class of employees from the Pantex Plant in Amarillo, Texas, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, NIOSH, 1090 Tusculum Avenue, MS C–46, Cincinnati, OH 45226–1938, Telephone 877–222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. SUPPLEMENTARY INFORMATION: SUMMARY: Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 7384l(14)(C). On January 4, 2017, as provided for under 42 U.S.C. 7384l(14)(C), the Secretary of HHS designated the following class of employees as an addition to the SEC: All employees of the Department of Energy, its predecessor agencies, and their contractors and subcontractors who worked at the Pantex Plant in Amarillo, Texas, during the period from January 1, 1951, through December 31, 1957, for a number of work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort. This designation became effective on February 3, 2017. Therefore, beginning E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Pages 11583-11585]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03598]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-7044-N]


Health Insurance Marketplace\SM\, Medicare, Medicaid, and 
Children's Health Insurance Programs; Meeting of the Advisory Panel on 
Outreach and Education (APOE), March 22, 2017

AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the next meeting of the Advisory Panel 
on Outreach and Education (APOE) (the Panel) in accordance with the 
Federal Advisory Committee Act. The Panel advises and makes 
recommendations to the Secretary of the U.S. Department of Health and 
Human Services (HHS) and the Administrator of the Centers for Medicare 
& Medicaid Services (CMS) on opportunities to enhance the effectiveness 
of consumer education strategies concerning the Health Insurance 
Marketplace\SM\,\1\ Medicare, Medicaid, and the Children's Health 
Insurance Program (CHIP). This meeting is open to the public.
---------------------------------------------------------------------------

    \1\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are 
service marks of the U.S. Department of Health & Human Services.

DATES: Meeting Date: Wednesday, March 22, 2017 8:30 a.m. to 4:00 p.m. 
eastern daylight time (e.d.t).
    Deadline for Meeting Registration, Presentations, Special 
Accommodations and Comments: Wednesday, March 8, 2017, 5:00 p.m., 
(e.d.t.).

ADDRESSES: Meeting Location: U.S. Department of Health & Human 
Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., 
Room 505A, Conference Room, Washington, DC 20201.
    Presentations and Written Comments: Presentations and written 
comments

[[Page 11584]]

should be submitted to: Thomas Dudley, Designated Federal Official 
(DFO), Office of Communications, Centers for Medicare & Medicaid 
Services, 7500 Security Boulevard, Mailstop S1-05-06, Baltimore, MD 
21244-1850 or via email at Thomas.Dudley@cms.hhs.gov.
    Registration: The meeting is open to the public, but attendance is 
limited to the space available. Persons wishing to attend this meeting 
must register at the Web site https://www.regonline.com/apoemar2017meeting or by contacting the DFO as listed in the FOR 
FURTHER INFORMATION CONTACT section of this notice, by the date listed 
in the DATES section of this notice. Individuals requiring sign 
language interpretation or other special accommodations should contact 
the DFO at the address listed in the ADDRESSES section of this notice 
by the date listed in the DATES section of this notice.

FOR FURTHER INFORMATION CONTACT: Thomas Dudley, Designated Federal 
Official, Office of Communications, CMS, 7500 Security Boulevard, Mail 
Stop S1-05-06, Baltimore, MD 21244-1850, 410-786-1442, email 
Thomas.Dudley@cms.hhs.gov. Additional information about the APOE is 
available on the Internet at: http://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through 
the CMS Press Office at (202) 690-6145.

SUPPLEMENTARY INFORMATION: 

I. Background

    The Advisory Panel for Outreach and Education (APOE) (the Panel) is 
governed by the provisions of Federal Advisory Committee Act (FACA) 
(Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth 
standards for the formation and use of federal advisory committees. The 
Panel is authorized by section 1114(f) of the Social Security Act (42 
U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 
U.S.C. 217a) and sec. 10(a) of Public Law 92-463 (5 U.S.C. App. 2, sec. 
10(a) and 41 CFR 102-3).
    The Secretary of the U.S. Department of Health and Human Services 
(HHS) (the Secretary) signed the charter establishing the Citizen's 
Advisory Panel on Medicare Education \2\ (the predecessor to the APOE) 
on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make 
recommendations to the Secretary and the Administrator of the Centers 
for Medicare & Medicaid Services (CMS) on the effective implementation 
of national Medicare education programs, including with respect to the 
Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 
(Pub. L. 105-33).
---------------------------------------------------------------------------

    \2\ We note that the Citizen's Advisory Panel on Medicare 
Education is also referred to as the Advisory Panel on Medicare 
Education (65 FR 4617). The name was updated in the Second Amended 
Charter approved on July 24, 2000.
---------------------------------------------------------------------------

    The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173) 
expanded the existing health plan options and benefits available under 
the M+C program and renamed it the Medicare Advantage (MA) program. We 
have had substantial responsibilities to provide information to 
Medicare beneficiaries about the range of health plan options available 
and better tools to evaluate these options. The successful MA program 
implementation required CMS to consider the views and policy input from 
a variety of private sector constituents and to develop a broad range 
of public-private partnerships.
    In addition, Title I of the MMA authorized the Secretary and the 
Administrator of CMS (by delegation) to establish the Medicare 
prescription drug benefit. The drug benefit allows beneficiaries to 
obtain qualified prescription drug coverage. In order to effectively 
administer the MA program and the Medicare prescription drug benefit, 
we have substantial responsibilities to provide information to Medicare 
beneficiaries about the range of health plan options and benefits 
available, and to develop better tools to evaluate these plans and 
benefits.
    The Affordable Care Act (Patient Protection and Affordable Care 
Act, Pub. L. 111-148, and Health Care and Education Reconciliation Act 
of 2010, Pub. L. 111-152) expanded the availability of other options 
for health care coverage and enacted a number of changes to Medicare as 
well as to Medicaid and the Children's Health Insurance Program (CHIP). 
Qualified individuals and qualified employers are now able to purchase 
private health insurance coverage through a competitive marketplace, 
called an Affordable Insurance Exchange (also called Health Insurance 
Marketplace\SM\ or Marketplace\SM\). In order to effectively implement 
and administer these changes, we must provide information to consumers, 
providers, and other stakeholders through education and outreach 
programs regarding how existing programs will change and the expanded 
range of health coverage options available, including private health 
insurance coverage through the Marketplace\SM\. The Panel allows us to 
consider a broad range of views and information from interested 
audiences in connection with this effort and to identify opportunities 
to enhance the effectiveness of education strategies concerning the 
Affordable Care Act.
    The scope of this panel also includes advising on issues pertaining 
to the education of providers and stakeholders with respect to the 
Affordable Care Act and certain provisions of the Health Information 
Technology for Economic and Clinical Health (HITECH) Act enacted as 
part of the American Recovery and Reinvestment Act of 2009 (ARRA).
    On January 21, 2011, the Panel's charter was renewed and the Panel 
was renamed the Advisory Panel for Outreach and Education. The Panel's 
charter was most recently renewed on January 21, 2017, and will 
terminate on January 21, 2019 unless renewed by appropriate action.
    Under the current charter, the APOE will advise the Secretary and 
the Administrator on optimal strategies for the following:
     Developing and implementing education and outreach 
programs for individuals enrolled in, or eligible for, Medicare, 
Medicaid, and the Children's Health Insurance Program (CHIP), or 
coverage available through the Health Insurance Marketplace\SM\.
     Enhancing the federal government's effectiveness in 
informing Health Insurance Marketplace\SM\, Medicare, Medicaid, and 
CHIP consumers, issuers, providers, and stakeholders, through education 
and outreach programs, on issues regarding these programs, including 
the appropriate use of public-private partnerships to leverage the 
resources of the private sector in educating beneficiaries, providers, 
and stakeholders.
     Expanding outreach to vulnerable and underserved 
communities, including racial and ethnic minorities, in the context of 
Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP 
education programs.
     Assembling and sharing an information base of ``best 
practices'' for helping consumers evaluate health coverage options.
     Building and leveraging existing community infrastructures 
for information, counseling, and assistance.
     Drawing the program link between outreach and education, 
promoting consumer understanding of health care coverage choices, and 
facilitating consumer selection/enrollment, which in turn support the 
overarching goal of improved access to quality care, including 
prevention services, envisioned under the Affordable Care Act.

[[Page 11585]]

    The current members of the Panel are: Kellan Baker, Associate 
Director, Center for American Progress; Robert Blancato, President, 
Matz, Blancato & Associates; Dale Blasier, Professor of Orthopaedic 
Surgery, Department of Orthopaedics, Arkansas Children's Hospital; 
Deborah Britt, Executive Director of Community & Public Relations, 
Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of 
Pediatrics & Public Health, The Ohio State University, Nationwide 
Children's Hospital; Josephine DeLeon, Director, Anti-Poverty 
Initiatives, Catholic Charities of California; Robert Espinoza, Vice 
President of Policy, Paraprofessional Healthcare Institute; Louise 
Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center 
at Johns Hopkins; Roanne Osborne-Gaskin, M.D., Senior Medical Director, 
MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian 
American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation 
Support, Independent Contractor; Brendan Riley, Outreach and Enrollment 
Coordinator, NC Community Health Center Association; Alvia Siddiqi, 
Medicaid Managed Care Community Network (MCCN) Medical Director, 
Advocate Physician Partners, Carla Smith, Executive Vice President, 
Healthcare Information and Management Systems Society (HIMSS); Tobin 
Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors; 
and Paula Villescaz, Senior Consultant, Assembly Health Committee, 
California State Legislature.

II. Provisions of This Notice

    In accordance with section 10(a) of the FACA, this notice announces 
a meeting of the APOE. The agenda for the March 22, 2017 meeting will 
include the following:

 Welcome and listening session with CMS leadership
 Recap of the previous (September 21, 2016) meeting
 Affordable Care Act initiatives
 An opportunity for public comment
 Meeting summary, review of recommendations, and next steps

    Individuals or organizations that wish to make a 5-minute oral 
presentation on an agenda topic should submit a written copy of the 
oral presentation to the DFO at the address listed in the ADDRESSES 
section of this notice by the date listed in the DATES section of this 
notice. The number of oral presentations may be limited by the time 
available. Individuals not wishing to make an oral presentation may 
submit written comments to the DFO at the address listed in the 
ADDRESSES section of this notice by the date listed in the DATES 
section of this notice.

III. Security, Building, and Parking Guidelines

    This meeting will be held in a federal government building; 
therefore, federal security measures are applicable. The Real ID Act, 
enacted in 2005, establishes minimum standards for the issuance of 
state-issued driver's licenses and identification (ID) cards. It 
prohibits federal agencies from accepting an official driver's license 
or ID card from a state unless the Department of Homeland Security 
determines that the state meets these standards. Beginning October 
2015, photo IDs (such as a valid driver's license) issued by a state or 
territory not in compliance with the Real ID Act will not be accepted 
as identification to enter federal buildings. Visitors from these 
states/territories will need to provide alternative proof of 
identification (such as a valid passport) to gain entrance into CMS 
buildings. The current list of states from which a federal agency may 
accept driver's licenses for an official purpose is found at http://www.dhs.gov/real-id-enforcement-brief. We recommend that confirmed 
registrants arrive reasonably early, but no earlier than 45 minutes 
prior to the start of the meeting, to allow additional time to clear 
security. Security measures include the following:
     Presentation of government issued photographic 
identification to the Federal Protective Service or Guard Service 
personnel.
     Inspection of vehicle's interior and exterior (this 
includes engine and trunk inspection) at the entrance to the grounds. 
Parking permits and instructions will be issued after the vehicle 
inspection.
     Inspection, via metal detector or other applicable means, 
of all persons entering the building. We note that all items brought 
into CMS, whether personal or for the purpose of presentation or to 
support a presentation, are subject to inspection. We cannot assume 
responsibility for coordinating the receipt, transfer, transport, 
storage, set up, safety, or timely arrival of any personal belongings 
or items used for presentation or to support a presentation.

    Note: Individuals who are not registered in advance will not be 
permitted to enter the building and will be unable to attend the 
meeting. The public may not enter the building earlier than 45 
minutes prior to the convening of the meeting.

    All visitors must be escorted in areas other than the lower and 
first floor levels in the Central Building.

    Authority: Sec. 1114(f) of the Social Security Act (42 U.S.C. 
1314(f)), sec. 222 of the Public Health Service Act (42 U.S.C. 
217a), and sec. 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2, sec. 10(a) 
and 41 CFR 102-3).

    Dated: February 16, 2017.
Patrick Conway,
Acting Administrator Centers for Medicare & Medicaid Services.
[FR Doc. 2017-03598 Filed 2-23-17; 8:45 am]
BILLING CODE 4120-01-P